Triple-Combination Therapy with Olmesartan, Amlodipine, and Hydrochlorothiazide in Black and Non-Black Study Participants with Hypertension: The TRINITY Randomized, Double-Blind, 12-Week, Parallel-Group Study

Author： Chrysant Steven G.  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.12, Iss.4, 2012-08, pp. : 233-243

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Tolerability of Olmesartan Medoxomil Combined with Amlodipine in Patients with Moderate to Severe Hypertension after Amlodipine Monotherapy: A Randomized, Double-Blind, Parallel-Group, Multicentre Study

By Volpe Massimo  

Clinical Drug Investigation, Vol. 29, Iss. 1, 2009-01 ,pp. : 11-25

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Olmesartan Medoxomil 40 mg/Hydrochlorothiazide 12.5 mg Combination Therapy versus Olmesartan Medoxomil 40 mg Monotherapy in Patients with Moderate to Severe Hypertension: A Randomized, Double-Blind, Parallel-Group, Multicentre, Multinational, Phase III Study

By Fogari Roberto  

Clinical Drug Investigation, Vol. 30, Iss. 9, 2010-09 ,pp. : 581-597

Adis International

Access to resources Recommend Favorite

Olmesartan Medoxomil plus Amlodipine Increases Efficacy in Patients with Moderate-to-Severe Hypertension after Monotherapy: A Randomized, Double-Blind, Parallel-Group, Multicentre Study

By Barrios Vivencio  

Clinical Drug Investigation, Vol. 29, Iss. 7, 2009-06 ,pp. : 427-439

Adis International

Access to resources Recommend Favorite

Effective Systolic Blood Pressure Reduction with Olmesartan Medoxomil/Amlodipine Combination Therapy: Post Hoc Analysis of Data from a Randomized, Double-Blind, Parallel-Group, Multicentre Study

By Mourad Jean-Jacques   >  

Clinical Drug Investigation, Vol. 29, Iss. 6, 2009-05 ,pp. : 419-425

Adis International

Access to resources Recommend Favorite

Combination Therapy with Candesartan Cilexetil 32 mg and Hydrochlorothiazide 25 mg Provides the Full Additive Antihypertensive Effect of the Components: A Randomized, Double-Blind, Parallel-Group Study in Primary Care

By Edes Istvan  

Clinical Drug Investigation, Vol. 29, Iss. 5, 2009-01 ,pp. : 293-304

Adis International

Access to resources Recommend Favorite